Recent

% | $
Quotes you view appear here for quick access.

SIGA Technologies Inc. Message Board

spectrollmicro 24 posts  |  Last Activity: 24 minutes ago Member since: Feb 10, 2016
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    AML

    by vm779460 Mar 15, 2016 8:06 AM
    spectrollmicro spectrollmicro Mar 16, 2016 11:13 AM Flag

    CPXX continues higher after announcing inferior results to Pracinost + atazacitidine combination therapy.

    MEI management feels no compunction to make any press release based on their own superior results. Volume on stock & price looks like MEI has announced closing door as the stock trades below cash with no debt and getting ready to start ME-344 phase 2 cervical and other cancers in the next couple months and phase 3 clinical for highly successful pracinostat + azacitidine for AML a couple months later

    Unbelievable !

    Sentiment: Strong Buy

  • spectrollmicro by spectrollmicro Mar 15, 2016 9:55 AM Flag

    It would make sense for CELG to partner with MEI to make their own drug azacitidine (Vidaza) more marketable. Since pracinostat + azacitidine (Vidaza) combination is in MEIP phase 2 and phase 3 that is starting soon. Vidaza by itself is not an answer to AML, but when combined with pracinostat is very successful..

    Sentiment: Strong Buy

  • Reply to

    AML

    by vm779460 Mar 15, 2016 8:06 AM
    spectrollmicro spectrollmicro Mar 15, 2016 9:07 AM Flag

    the difference is pracinostat + azacitidine results in AML of 16 months median & 56% OS just going into phase 3 so an investor gets in here, at this ridiculous low price $1.20 in contrast to CPXX

    Sentiment: Strong Buy

  • spectrollmicro by spectrollmicro Mar 15, 2016 9:01 AM Flag

    with their pracinostat + azacitidine for AML entering phase 3 resulting in 16 months median and OS of 56%

SIGA
0.825+0.0750(+10.00%)3:19 PMEDT